AbbVie Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 48.0B 54.3B 58.1B 56.2B
Cost of revenue 14.4B 20.4B 17.4B 17.4B
Gross profit 33.6B 33.9B 40.6B 38.8B
Operating expense
Research & development 10.9B 8.5B 7.2B 8.0B
Selling general and admin 12.6B 12.9B 15.3B 12.3B
Other operating expenses -6.0M -179M 56M 432M
Operating income 10.1B 12.8B 18.1B 17.9B
Non operating interest income
Income 552.3M 540M 186M 39M
Expense 2.4B 2.2B 2.2B 2.4B
Other income expense -5.1B -4.8B -2.6B -2.6B
Pretax income 3.2B 6.3B 13.5B 13.0B
Tax provision -485.8M 1.4B 1.6B 1.4B
Net income 3.7B 4.9B 11.8B 11.5B
Basic EPS 2.4 2.7 6.7 6.5
Diluted EPS 2.4 2.7 6.6 6.5
Basic average shares 1.5B 1.8B 1.8B 1.8B
Diluted average shares 1.5B 1.8B 1.8B 1.8B
EBITDA 15.1B 17.3B 24.3B 24.0B
Net income from continuing op. 3.7B 4.9B 11.8B 11.5B
Minority interests -8M -10M -9M -7M
Preferred stock dividends 34.1M 43M 54M 74M
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 19 minutes

12:15
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).